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ABSTRACT 
 
Probiotic, Lactic Acid Bacteria are associated with normal microbial ecosystem of 
gastrointestinal tract of human and fish and plays a vital role during in-vivo interactions 
occurring in Gastro Intestinal Tract (GI) of human beings, hence exert health benefits beyond 
inherent basic nutrition. In the recent study, some potential probiotic lactic acid bacteria were 
screened from fresh water fish intestine. Sixteen strains have been selected on the basis of 
growth in Lactobacillus selective media (MRS) and subjected to Gram staining, Catalase 
activity and Oxidase test. Out of these, 6 strains have been selected for further studies on the 
basis of morphology, Lactobacillus specific biochemical test and amplification of 
Lactobacillus genus specific gene. Five strains named (KTIT, KT2W, KT1B, KA2, FS) have 
been identified as Lactobacillus casei. Sixth strain has been identified and named as KT1, 
Lactobacillus delbrueckii on the basis of bergey's manual of systematic bacteriology. Out of 
these six strains KT1 has proved its probiotic credibility more by producing antimicrobial 
Bacteriocin-like compound, which were having inhibitory property against potential 
pathogenic strains. Strain KT1 was found to be more potential probiotic lactic acid bacteria 
after further identification by biochemical analysis and molecular identification (16s rDNA 
Sequencing) was done. The study is extremely promising, that underscores the important role 
of Lactobacillus strains, having probiotic effects, which may play an important role in food 
industry as starter-culture, co-culture and bio protective cultures to improve quality and 
safety of preserved food and beverages. 
 
Key words: Probiotics, Lactic acid bacteria, Fish intestine, Bacteriocin, Molecular                     
analysis. 
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1. INTRODUCTION 
Probiotics are defined as “living micro-organisms, which on ingestion in specific numbers 
exerts health advantages beyond inherent basic nutrition” (Guarner and Schaafsma, 1998; 
Tannock, 2002) still interest in this area was initiated by Metschnikov 100 years ago 
(Metschnikoff, 1907). Traditionally, the lactic acid bacteria (LAB) are defined by formation 
of lactic acid as a sole or main end-product from carbohydrate metabolism. They are 
associated with normal microbial ecosystem of gastrointestinal tract of human and fish. 
Lactic acid bacteria comprise a diverse group of non-spore forming, Gram-positive bacteria. 
They occur as cocci or rods and are generally lacking catalase, although pseudo-catalase can 
be found in rare cases. They are chemoorganotrophic and grow only in complex media. 
Fermentable carbohydrates are consumed as energy source. Hexoses are degraded primarily 
to lactate (homofermentatives) or to lactate and additional products such as acetate, ethanol, 
CO2, formate or succinate (heterofermentatives). Lactic acid bacteria are present in foods 
(dairy products, sour dough, fermented meat, fermented vegetables, silage, beverages), in 
sewage, on plants, as well as within the genital, intestinal and respiratory tracts of humans 
and animals (Schleifer and Ludwig, 1995; Hammes et al., 1991). Lactic acid bacteria (LAB) 
produce a variety of low molecular mass compounds together with acids, alcohols, carbon 
dioxide, diacetyl, hydrogen peroxide and different metabolites. Several of those metabolites 
have a broad activity spectrum against different species, and their production is basically 
affected by the food matrix itself. 
 
Lactic acid bacteria produce a variety of antagonistic factors that consists of end products 
which are produced metabolically, bactericidal proteins and antibiotic-like substances termed 
bacteriocins. The rate of inhibitory activity by bacteriocins of lactic acid bacteria can be 
either narrow inhibiting only those strains that are closely related to the producer organism, 
inhibiting a diverse group of Gram-positive microorganisms. Bacteriocins of LAB are 
considered as safe natural preservatives or biopreservatives, because it is assumed that they're 
degraded by the proteases in gastrointestinal tract (Cleveland et al., 2001). Bacteriocins are 
extracellularly released peptides or protein molecules, with a bacteriostatic mode of action 
against closely related species. The inhibitory spectrum of several bacteriocins also includes 
food spoilage and/or food-borne pathogenic microorganisms (Schillinger et al., 1996). The 
discovery of nisin, the first bacteriocin utilized on a commercial scale as a food preservative 
dates back to the first half of last century but research on bacteriocins of LAB has expanded 
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in the last two decades, looking for novel bacteriocin producing strains from dairy, meat, 
plant products, and traditional fermented products. Various bacteriocins have been isolated 
and characterized (Cleveland et al., 2001). Lactic acid bacteria (LAB) consist of a number of 
bacterial genera within the phylum Firmicutes. The genera Carnobacterium, Lactobacillus, 
Lactococcus, Lactosphaera, Melissococcus, Pediococcus, Streptococcus, Tetragenococcus 
and Weissella are recognized as LAB (Stiles and Holzapfel, 1997). 
 
Due to emergence of multi-drug resistant bacteria as serious problem over the past decades, 
major analysis efforts are aimed toward finding effective drugs. Under such conditions Lactic 
acid bacteria and their metabolites are good alternatives as a source of antimicrobial agents. 
Primarily Lactobacillus and Bifidobacterium species are found in several dairy foods, normal 
inhabitants of the human gut and supplements and are currently attracting keen interest as 
health supplements from both consumers and researchers due to heightened awareness of the 
beneficial connections among health, diet and nourishment. 
 
The properties expected from potential probiotic strains of lactic acid bacteria, compiled by 
many authors (Kullen and Klaenhammer, 1999; Veld and Shortt, 1996; Havenaar et al., 1992; 
Salminen et al., 1996; Tannock 1997) are: 
a) Accurate taxonomic identification. 
b) Normal inhabitant of the species targeted human origin for human probiotics. 
c) Nontoxic and non-pathogenic. 
d) Genetically stable. 
e) Capable of survival, proliferation, and metabolic activity at the target area. 
f) Adherance and colonization potential preferred. 
g) Stability of desired characteristics during culture preparation, storage, and 
delocalisation. 
h) Viability at high populations preferred at 106 – 108 
i) Production of antimicrobial substances, as well as bacteriocins, hydrogen peroxide 
and organic acids. 
j) Antagonistic for pathogenic/cariogenic bacteria. 
k) Able to compete with the normal microflora, as well as the same or closely related 
species; potentially resistant to acid, bacteriocins and other antimicrobials produced 
by residing microflora. 
l) Resistant to bile. 
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m) Resistant to acid. 
n) Immunostimulatory. 
o) Able to exert one or more clinically documented health benefits. 
p) Amenable to production processing adequate growth, concentration, recovery, 
freezing, dehydration, storage and distribution.  
q) Provision of suitable organoleptic qualities (or no undesirable qualities) when 
included in fermented products. 
 
Microorganisms used as probiotics:  
 Lactobacillus acidophilus 
 L.plantarum 
 L. casei 
 L. casei subsp. Rhamnosus 
 L. delbreuckii subsp. Bulgaricus 
 L. fermentum 
 L.reuteri 
 Lactococcuslactis subsp. Lactis 
 L. lactis subsp. Cremoris 
 Bifidobacteriumbifidum 
 B. infantis 
 B.adolescentis 
 B. longum 
 B. breve 
 Streptococcus salivarius subsp. Thermophiles 
 Enterococcus faecalis 
 E.faecium 
 Saccharomyces boulardii 
 
The immune system of mammals includes a complex array of cells and molecules, which 
interact to produce protection from challenge by pathogenic microbes (bacteria, viruses, 
parasites). Antigens are substances that induce an immune response, are usually parts of 
invading microbes. Varied organs participate during this immune response. As an example, 
the central lymphoid organs (bone marrow, thymus) contribute towards the ontogenesis of the 
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different immune cells, whereas the peripheral lymphoid organs (spleen, lymph nodes, 
mucosal lymphoid tissue) orchestrate the immune response. Most of the antigens penetrate 
into the body through the mucosa and the mucosal immune system of the host plays a key 
role in the defense response to pathogens. The intestinal microbiota is that the largest supply 
of microbial stimulation that exerts both harmful and beneficial effects on human health. 
Therefore, it acts as a primary agent because it participates in the development of the 
postnatal immune system as well as oral tolerance and immunity. It’s possible that the 
microbiota acquired during and immediately after birth is necessary for the newborn’s 
systemic and mucosal immunity, and it should also be responsible for controlling 
inflammatory responses in allergic and inflammatory bowel diseases. If so, probiotics may 
impede these inflammatory processes by stabilizing the intestinal microbial environment and 
intestinal permeability barrier by fostering the degradation of enteric antigens and altering 
their immunogenicity. The leading proposed explanations for the action mechanisms of 
probiotics against bacterial pathogens are immunostimulation and immunomodulation. Lots 
of various immunologic studies have been made in the probiotic field using different strains 
and different models. The objective of this review was to create the point about the 
immunological potential of probiotic and to highlight what is already acquired and what is the 
direction to take to better define an immunologic profile of a probiotic strain. An excellent 
review (Cummings et al., 2004) gave excellent explanations regarding the normal function of 
the gut and the immune system in healthy person with a detailed description of the systemic 
and mucosal immunity. Our review is split into two parts. The first, discussing the work of 
(Cummings et al., 2004), briefly described the key actors and answers of the innate and 
adaptive immune system (1) and the mucosal immune system (2). The second half is 
concentrated on the interactions between probiotics and intestinal epithelium and their impact 
in innate immunity (3), adaptive immunity (4) and particularly on the Th1/Th2 balance (5). 
The in vitro tests show the cytokine profile of probiotic strains are described (6) and clinical 
studies evaluating the effects of probiotics in the treatment of several chronic inflammatory 
diseases and allergies are reported (7). 
Probiotic cultures are associated traditionally with cultured of milks and dairy product, from 
which there's substantial proof for positive effects on human health and general well-being 
(Kaenhammer, 2000; Reuter, 2001). Many in vitro and in vivo experiments on antagonism of 
various Lactobacillus strains against Helicobacter pylori and Clostridium difficile, 
Campylobacter jejuni, E. coli was done. All tested human Lactobacillus strains are able to 
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inhibit the expansion of all strains of anaerobic human gastrointestinal pathogens. 
Additionally, bacteriocins have properties like antitumour and anticholestrol activity. 
Chemical reactions are related to reduction of nitrate, improvement in immunological status 
and adsorption of vitamins B group. The transity lactic acid bacteria among the GI tract are 
capable of delivering enzymes and different substances into the intestine that probably 
facilitate to regulate the intestinal flora (Collins et al., 1999). Also, the antioxidative activity 
of lactic acid bacteria is reported. Due to inhibitory impact, selected probiotic lactobacilli 
could also be used as biological preservative, so, the objective of this study was to provide 
information on isolation, growth antimicrobial activity, impact of pH, heat, and sensitivity to 
proteolytic enzymes of lactobacillus as probiotic bacteria. 
Growing human population urges the immense need to exploit the existing livestock 
resources to meet the animal protein requirements. The concept of helpful microbes is 
hundred years old when the people were in habit of consuming fermented milk. (Lilly and 
Stillwell, 1965), first time, used the word “probiotic” for this kind of microbes and described 
that probiotics are substances secreted by one microorganism that stimulate the growth of 
others. (Fuller, 1989) defined it as a live microbial feed supplement, that beneficial for the 
host animal by improving the intestinal microbial balance. The application of probiotics in 
poultry has gained considerable interest during the last few years because antibiotic growth 
promoters (AGPs), added to animal feed to increase growth and decrease the incidence of 
diseases, are leaving harmful residues in meat and eggs. The most commonly used organisms 
in probiotic preparations are lactic acid producing bacteria such as lactobacilli, streptococci, 
Bifidobacteria and fungi such as Sacharomyces cerevisiae, Sacharomyces boulardii and 
Aspergillus oryzae (Medina et al., 2001). However, lactic acid bacteria (LAB) have attained 
major attention for probiotic activity and have generally been considered as good probiotic 
organisms (Saavedra, 2001; Sullivan et al., 1992). Among lactic acid bacteria, lactobacilli are 
the most important. The crop and ileum flora are mainly composed of lactobacilli in poultry 
(Fuller, 1984). Many lactobacillus strains isolated from various sources are being used as 
probiotic agents and it is unlikely that each species/strain possesses all of the desired 
characters that will make it a suitable probiotic. The functional properties of the strains 
should be well studied and documented. The present study was aimed at isolating and 
characterizing lactobacilli from avian microbiota and fermented milk products and to study 
probiotic properties of these isolated lactobacillus species for their use in chicken. 
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The modern term ‘probiotic’ was first used by Fuller (Fuller, 1989), a live microbial feed 
supplement which beneficially affects the host animal by improving its microbial balance. 
After that it was demonstrated as heat-inactivated bacteria or fragments of bacterial DNA 
have positive effects as well. (Marteau et al., 2002) defined probiotics as ‘microbial cell 
preparations or components of microbial cells that have a beneficial effect on the health and 
wellbeing’. The mechanisms by which probiotics beneficially affect the host are multiple. 
Probiotics can prevent or ameliorate diarrhoea and inflammation through their local effects 
and/or their effect on the immune system. In the gut, probiotic bacteria may occupy binding 
sites on the gut mucosa, preventing pathogenic bacteria binding to the mucosa. Lactobacilli 
produce proteinaceous compounds, particularly bacteriocins, that act as local antibiotics 
against more pathogenic organisms and decrease production of pro-inflammatory cytokines 
such as IFN-γ, TNF-α and IL-12. Probiotics stimulate IgA production (Kaila et al., 1992). 
Lactobacilli give acetic and lactic acid and inhibit the growth of bacterial pathogens. It has 
been postulated that probiotics compete with pathogens for nutrients and modify toxins 
produced by pathogens or toxin receptors found in the gut wall. (Saavedra, 1995) have shown 
that specific DNA repeats isolated from probiotics can attenuate experimental colitis in 
various animal models. This is true even with inactivated bacteria. By using toll-like receptor 
9 (TLR-9) deficient mice, they have showed that TLR9 signaling was essential in mediating 
the anti-inflammatory effect of probiotics. Prerequisites for probiotics are to be effective and 
safe. The properties of an good probiotic defined by Saavedra (Saavedra, 1995) are resistance 
to digestion by enteric or pancreatic enzymes, gastric acid and bile, ability to stop the 
adherence, establishment and replication of pathogens in the gastrointestinal tract (GI Tract). 
The examples of probiotic bacteria are members of the Lactobacilli family such as 
Lactobacillus Rhamnosus GG, Bifidobacteria and the yeast Saccharomyces Boulardii. There 
are many bacteria which can be qualified as probiotics, but different bacteria have unlike 
actions in different disease states, taking into explanation that some disease are better treated 
with a combination of bacteria and that there is an issue of dosing and viable vs. non-viable 
elements of the bacteria. Treatment with probiotics can safe, but it was not risk free. 
Probiotics are potentially pathogenic. A recent report describes 3 patients with fungemia in 
whom the probiotic origin was proven by DNA fingerprinting (Munoz et al., 2005). Reports 
of infections of probiotic origin emphasize the fact that these patients are usually 
immunosupressed with multiple ports of entry, like venous and urinary catheter. 
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Probiotic Lactobacillus is known to confirm various health promoting activities on their host 
after either parenteral or oral administration in rats. Some of their beneficial effects include 
prevention of intestinal infection (Tannock, 1983), control of serum cholesterol, enhancement 
of immunity in human and rats, and growth enhancement of poultry and pigs. The 
mechanisms by which these probiotics affect their host and improve gut barrier can be due to: 
competition for adhesion site, production of inhibitory compounds, and rebalancing of 
interrupted gastrointestinal (GI) microbial composition and metabolism. Lactobacilli are not 
regular inhabitants of the digestive tract in rabbits and poorly adhere to epithelial cells; 
therefore, their usefulness is doubtful in such species. Studies on different clinical approaches 
in pet rabbits (Fann et al., 2001) showed that Lactobacillus can be successfully used in 
therapies instituted for antibiotic-associated enteritis, and suggested two possible mechanisms 
of action. The first is that Lactobacillus has been shown to have an inhibitory effect on 
pathogenic E. coli and so it would be useful in the event of E. coli population. The second 
theory is that, also in rabbit, Lactobacillus is a normal gut inhabitant (Das et al., 1997) that 
may be eradicated with inappropriate antibiotic administration. Another condition is that, 
being living microrganisms, the application of probiotics to a large number of animals as 
under commercial conditions must be effective, should be administered early in life as 
possible, and should understate uncontrolled variables such as water quality and proportioner/ 
medicator function and consistency. These cosequences can be addressed and minimized if 
the probiotic were administered by spray application, as observed in poultry.  
Interest in the role of probiotics for human health goes back at least as far as 1908 
when Metchnikoff suggested that man should consume milk fermented with lactobacilli to 
prolong life. It is only recently, however, that the interrelationship between intestinal 
microorganisms and the health benefits deriving from it are beginning to be understood. 
Presently it is generally recognised that an optimum ‘balance’ in microbial population in our 
digestive tract is associated with good nutrition and health. The microorganisms primarily 
related to this balance are Lactobacilli and Bifidobacteria. Factors that negatively effects the 
interaction between intestinal microorganisms, like stress and diet, tends to detrimental 
effects in health. Increasing evidence indicates the consumption of ‘probiotic’ 
microorganisms can help maintain such a favourable microbial profile and results in several 
therapeutic benefits. Recently probiotic bacteria have increasingly been incorporated into 
foods as dietary adjuncts. One of the most famous dairy products for the delivery of viable 
Lactobacillus acidophilus and Bifidobacterium bifidum cells is bio-yogurt. Sufficient number 
of viable cells, such as the ‘therapeutic minimum’ needs to be consumed regularly for 
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transfer of the ‘probiotic’ effect to consumers.  Lactobacillus acidophilus non-pathogenic and 
a member of the normal intestinal microflora is widely used in fermented dairy products and 
is of considerable industrial and medical interest because it has been reported to aid in the 
reduction of the levels of harmful bacteria and yeasts in the small intestine and to produce 
lactase, an enzyme which is important for the digestion of milk (Deraz et al., 2007). So, L. 
acidophilus group of lactic acid bacteria (LAB) is added as dietary adjuncts to commercial 
fermented milk products and the intake of these bacteria may have beneficial effects on 
human health. The properties of L. acidophilus have been investigated in order to establish its 
specific role in the complex microbial intestinal equilibrium, both of man and higher animals. 
The L. acidophilus has been considered to be the predominant lactobacillus in the intestinal 
tract of healthy humans (Ray, 1996). L. acidophilus strains have been widely utilized as a 
dairy starter culture for their therapeutic activities associated with an intestinal microbial 
balance, and has been used in fermented foods, and as an probiotic in dietary supplements. 
Recent in vitro studies showed that L. acidophilus is a strong Th1 cytokine (IL-12, IFN-ᵞ) 
inducer. L. acidophilus significantly up-regulated surface markers on dendritic cells (DCs), 
including HLA-DR, CD40, CD86 and CD83. There is an increasing interest in the research of 
antimicrobial peptides (bacteriocins and bacteriocin-like compounds) produced by lactic acid 
bacteria (LAB) because of their potential use as antimicrobial agents for  improving the 
safety of food products. Among Lactobacilli, strains belonging to species of the L. 
acidophilus complexes are most frequently used as probiotics. Bacteriocin production is often 
proposed as a beneficial characteristic of probiotic bacteria (Klaenhammer and Kullen, 1999). 
It may contribute to the colonisation resistance of the host and its protection against 
gastrointestinal pathogens. As the bacteriocin producing strain L. acidophilus IBB 801, a 
dairy isolate, shows antibacterial activity against Escherichia coli and Salmonella, the authors 
told that it may have potential as a probiotic. Numerous reports have proved the power of L. 
acidophilus strains to produce bacteriocins. L. acidophilus strains exhibiting antagonistic 
activity towards certain types of psychrotrophic microorganisms such as Listeria 
monocytogenes, Bacillus cereus, and Clostridium sp. were especially important as these 
microorganisms even at low levels in food pose a significant spoilage and public health 
threat. Bacteriocins are lethal to closely related bacteriocin associated species, food-borne 
pathogens and spoilage bacteria (Klaenhammer, 1993). Among the Lactobacillus species, L. 
acidophilus strains have been extensively utilized as probiotic cultures in dairy and 
pharmaceutical products and numerous reports have proved its ability to produce 
bacteriocins, yet no review has been published summarizing its bacteriocin production.  Since 
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(Metchnikoff, 1908) proposed a role for Lactobacilli in suppressing undesirable intestinal 
microflora, numerous researchers have investigated the antimicrobial activities of L. 
acidophilus. Broad spectrum inhibition has been clearly demonstrated for organic acids and 
hydro-gen peroxide produced by L. acidophilus. In addition, a number of reports suggest that 
antimicrobial proteins, or bacteriocins, either mediate or facilitate antagonism by L. 
acidophilus. (Vincent et al., 1959) first described a bacteriocin-type inhibitor produced in 
aged liver veal agar cultures of L. acidophilus. Crude "lactocidin" was non-volatile, non-
dializable, insensitive to catalyze, active at neutral pH and displayed inhibitory activity 
against numerous genera, including Proteus, Salmonella, Escherichia, Staphylococcus, 
Bacillus, Streptococcus, and L. actobacillus. No further studies on lactocidin, or similar 
broad-spectrum bacteriocins produced by L. acidophilus has been reported. However 
previous studies of antagonism by L. acidophilus do not specifically address, identify, or 
confirm the involvement of bacteriocins. 
 
The objectives of the current work are given below: 
1) Isolation of LAB from fish intestine by growing on Lactobacillus selective media 
(MRS) in anaerobic Condition. 
2) Selection of LAB by amplification of Lactobacillus specific gene. 
3) Inhibitory action of isolated LAB strains against Bacillus sp., Klebsiella sp., Proteous 
sp., E. coli, and Pseudomonas sp. 
4) Identification of potential probiotic LAB by biochemical as well as molecular 
characteristics.
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2. REVIEW OF LITERATURE 
 
2.1. PROBIOTICS 
The original observation of the positive role played by bound bacteria was 1st 
introduced by Russian scientist and Nobel laureate Elie Metchnikoff, who within the starting 
of the twentieth century urged that it'd be doable to switch the gut flora and to exchange 
harmful microbes with helpful microbes (Metchnikoff, 1907). Metchnikoff, proposed the 
hypothesis that the aging method results from the activity of putrefactive (proteolytic) 
microbes manufacturing toxic substances within the giant bowel. Proteolytic bacteria like 
Clostridia, that are a part of the traditional gut flora, manufacture toxic substances together 
with phenols, indols and ammonia from the digestion of proteins. According to Metchnikoff 
these compounds were liable for what he referred to as "intestinal autointoxication” that 
caused the physical changes related to adulthood. It absolutely was at that point known that 
milk fermented with lactic-acid bacteria inhibits the expansion of proteolytic bacteria thanks 
to the low pH created by the fermentation of lactose. Metchnikoff had conjointly observed 
that bound rural populations in Europe, for instance in Bulgaria and therefore the Russian 
steppes that lived largely on milk fermented by lactic-acid bacteria were exceptionally long 
lived. Primarily based on these facts, Metchnikoff proposed that consumption of fermented 
milk would "seed" the intestine with harmless lactic-acid bacteria and reduce the intestinal 
pH which this is able to suppress the expansion of proteolytic bacteria. Metchnikoff himself 
introduced in his diet bitter milk fermented with the bacteria he referred to as "Bulgarian 
Bacillus" and located his health benefited. Bifidobacteria were 1st isolated from a breast-fed 
infant by Henry Tissier. The isolated bacterium named Bacillus bifidus communis (Tissier, 
1900) was later renamed to the genus Bifidobacterium. Tissier found that bifidobacteria are 
dominant within the gut flora of breast-fed babies and he observed clinical advantages from 
treating diarrhoea in infants with bifidobacteria. The claimed result was bifidobacterial 
displacement of proteolytic bacteria inflicting the disease. Throughout a pestilence of 
shigellosis in 1917, German professor Alfred Nissle isolated a strain of Escherichia coli from 
the faeces of a soldier who wasn't suffering from the disease. Ways of treating infectious 
diseases were required at that point when antibiotics weren't nevertheless obtainable, and 
Nissle used the Escherichia coli strain in acute gastrointestinal infectious salmonellosis and 
shigellosis. In 1920, Rettger demonstrated that Metchnikoff's "Bulgarian Bacillus", later 
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referred to as Lactobacillus delbrueckii subsp. bulgaricus, couldn't live within the human 
intestine, (Cheplin and Rettger, 1920) and therefore the fermented food phenomenon 
diminished. Metchnikoff's theory was disputable, and folks doubted his theory of longevity. 
Once Metchnikoff's death in 1916, the centre of activity moved to the U.S. It absolutely was 
reasoned that bacteria originating from the gut were a lot of seemingly to provide the required 
result within the gut, and in 1935 bound strains of Lactobacillus acidophilus were found to be 
terribly active when implanted within the human digestive tract. Trials were administrated 
using this organism, and inspiring results were obtained particularly within the relief of 
chronic Constipation. The term "probiotics" was 1st introduced in 1953 by Werner Kollath 
(Hamilton-Miller et al. 2003). Contrasting antibiotics, probiotics were outlined as microbially 
derived factors that stimulate the expansion of different microorganisms. In 1989, Roy Fuller 
urged a definition of probiotics that has been widely used: "A live microbial feed supplement 
that beneficially affects the host animal by improving its intestinal microbial balance". 
(Fuller, 1989) Fuller's definition emphasizes the necessity of viability for probiotics and 
introduces the facet of a helpful result on the host. Within the following decades, intestinal 
lactic acid bacterial species with alleged health helpful properties are introduced as 
probiotics, together with Lactobacillus rhamnosus, Lactobacillus casei, and Lactobacillus 
johnsonii (Tannock, 2003). 
The application of probiotics in poultry has gained considerable interest during the 
last few years because antibiotic growth promoters (AGPs), added to animal feed to increase 
growth and decrease the incidence of diseases, are leaving harmful residues in meat and eggs. 
A wide range of microorganisms have been used as probiotics. The most commonly used 
organisms in probiotic preparations are lactic acid producing bacteria such as Lactobacilli, 
Streptococci, Bifidobacteria and fungi like Sacharomyces cerevisiae and Aspergillus oryzae 
(Fuller, 1992; Medina et al., 2001). However, lactic acid bacteria (LAB) have attained major 
attention for probiotic activity and have generally been considered as good probiotic 
organisms (Saavedra, 2001; Sullivan et al., 1992). Among lactic acid bacteria, Lactobacilli 
are the most important (Tannock, 2004). The crop and ileum flora are mainly composed of 
Lactobacilli in poultry (Fuller, 1984). Many Lactobacillus strains isolated from various 
sources are being used as probiotic agents and it is unlikely that each species/strain possesses 
all of the desired characters that will make it a suitable probiotic. The functional properties of 
the strains should be well studied and documented. The present study was aimed at isolating 
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and characterizing Lactobacilli from avian microbiota and fermented milk products and to 
study probiotic properties of these isolated Lactobacillus species for their use in chicken. 
 
2.1.1 EARLY HISTORY OF THE USE OF MICROORGANISMS FOR HUMAN   
         BENEFIT 
There is proof from wall carvings that cultured milk merchandise was created a 
minimum of 4500 years ago. Written proof for fermented milks seems in Genesis 18: eight, 
“He then brought some curds and milk that had been ready and set these before them”. The 
assembly of wine is cited in Genesis 9: twenty, “Noah a person of the soil, proceeded to plant 
a vineyard, where he drank a number of its wine, he became drunk and lay uncovered within 
his tent”. In Exodus 12: thirty-nine the utilization of microorganisms to arrange bread is 
cited: “They baked the dough that that they had brought out of Egypt into cakes of 
unleavened bread. The exodus from Egypt is believed to own occurred approximately in 1440 
B.C. Homer within the Iliad, written between 900 and 800 B.C. makes various references to 
wine and cheese. In book eleven of the Iliad there's the subsequent passage: “Pours an 
oversized portion of Pramnian wine; with goats milk cheese a flavourous style bestows, and 
last with flour the smiling surface stows”. The traditional production of wine, cheese and 
bread served variety of helpful functions. It altered the flavour and texture of the natural 
foods and within the case of milk merchandise extended the time of edible use by preventing 
speedy spoilage by random bacterial or fungal growth. Within the case of wine, additionally 
to its pleasurable mind-altering properties, wine was used as an anesthetic. During a 10th-
century Persian work, the Shahnameh, the utilization of wine was described for performing 
Caesarean sections. In India wine was used as an anesthetic by the surgeon Sushruta around 
600 B.C. so a protracted history exists for the utilization of microorganisms to learn the 
human condition. In additional recent times an early reference to the utilization of 
microorganisms for a particular medical condition was proposed by (Doderlein, 1892), during 
which year he proposed to treat vaginal infections with Lactobacilli. In 1900 Henry Tissier at 
the Pasteur Institute isolated a Bifidobacterium from a breast-fed infant (Tissier, 1905). This 
bacterium is currently designated Bifidobacterium bifidus. Tissier additionally showed that 
Bifidobacteria are the predominant organism found in breast-fed infant faeces and counseled 
administering this organism to infants with diarrhoea. In 1907 the utilization of a particular 
category of microorganisms to learn human health was introduced to the overall public by the 
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Nobel Prize winner Elie Metchnikoff. In his book The Prolongation of Life (1907), 
Metchnikoff stated his belief that bacteria within the colon were liable for adverse health in 
adults which consuming bitter milk or yogurt would counteract these harmful bacteria. He 
proposed that the strain “Bulgaricus Bacillus”, later named Lactobacillus bulgaricus, was the 
strain liable for conferring higher health and longer life in humans. In 1911 Douglas revealed 
The Bacillus of Long Life that supported the concept of human longevity and also the 
consumption of fermented milk. In 1917 Alfred Nissle isolated an Escherichia coli that he 
used to treat acute intestinal diseases like salmonellosis and shigellosis, with a big success 
rate. This organism is currently designated E. coli Nissle and remains used as a probiotic and 
is an example of a non-lactic acid bacteria probiotic. In 1935, Retteger at Yale University 
proposed that Lactobacillus acidophilus would be an acceptable species to use for human 
clinical trials (Retteger et al., 1935). This approach was followed by a study demonstrating 
positive results for patients with chronic constipation. The utilization of specific bacteria for 
human disorders dates to the Twenties however the term “probiotic” wasn't employed in this 
context till 1974. (Parker, 1974) described probiotics as “organisms and substances, that 
contribute to intestinal microbial balance”. In 2002, a EEC knowledgeable Committee 
outlined probiotics as “living microorganisms, that upon ingestion in adequate amounts exert 
health advantages beyond inherent general nutrition”. 
 
2.1.3 OVERVIEW OF PROBIOTIC STUDIES AND RESULTS FOR THE PAST 35  
         YEARS 
Based on the definitions for a probiotic expressed in 1974 and changed in 2002, a 
major variety of microorganisms are isolated and identified as probiotics. A number of these 
probiotics are fed to humans and animals to check, treat or forestall varied diseases, disorders 
and syndromes. The approximate variety of various bacterial strains in every genera that are 
attributed as probiotics are as follows: Lactobacillus, 23; Bifidobacterium, 5; E. coli, 2; and 
one strain every of Bacillus, Streptococcus, Enterococcus and Lactococcus. Additionally 
there's solely yeast, specifically Saccharomyces boulardii that has probiotic attributes 
(Sanders, 2007). With the corresponding isolation and identification of probiotic 
microorganisms there has been an increasing variety of basic researches, clinical analysis, 
clinical trial and intervention studies printed. Year to year, since the mid-1980s, the quantity 
of papers has increased exponentially. It'll not be doable in a very chapter or a book to hide 
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all the studies in print and thus the subsequent sections describe the highlights of the findings 
on health advantages. 
2.1.4 CURRENT EVIDENCE FOR PROBIOTIC HEALTH BENEFITS 
2.1.4.1 Lactose Intolerance 
Worldwide several scores of individuals expertise lactose malabsorption. The 
frequency of the disorder will increase with age. The cause for this disorder may be a decline 
within the activity of the enzyme lactase within the intestinal brush border mucosa. This 
decline in activity ends up in lactose malabsorption. This incomplete absorption causes flatus, 
bloating, abdominal cramps, and moderate to severe diarrhoea. A serious consequence of this 
sequence of events may be a severe limitation in consumption of dairy merchandise, that is 
especially pronounced within the elderly. Many studies have demonstrated that in the 
fermentation of milk to create yogurt lactase is made and on consumption of yogurt this 
lactase is active within the intestinal tract (Kim and Gilliland, 1983; Kolars et al., 1984). The 
organisms used for the assembly of yogurt are Lactobacillus delbrueckii subsp. bulgaricus 
and Streptococcus thermophilus. (Kim and Gilliland, 1983) found that feeding yogurt to 
participants who were lactose-intolerant caused a major reduction within the levels of 
hydrogen found within the breath compared with feeding milk to subjects with constant 
condition. the extent of hydrogen within the breath reflects the intestinal microflora 
metabolism of lactose not absorbed within the little intestine and therefore gift within the 
colon, where the microflora are gift in high concentrations. (Kolars et al., 1984) found that 
subjects who ingested eighteen g of lactose in yogurt had sixty seven less hydrogen in their 
breath compared with constant lactose dose delivered in milk. An analysis of intestinal 
duodenal aspirates obtained from the themes consuming yogurt indicated that there have been 
vital levels of lactase within the duodenum. A scientific review of the printed literature in 
2005 analysing studies of probiotic treatment of adult lactose intolerance concluded that the 
proof doesn't support the effectiveness of probiotics for treatment of this disorder (Levri et 
al., 2005). However, the authors conclude that this could result from the variation within the 
nature or variety of probiotic employed in the particular study. For instance, lactobacilli that 
have low levels of lactase may be potential confounder. The strains selected for yogurt 
production have high lactase levels, needed for the economical preparation of yogurt. 
2.1.4.2. Inflammatory bowel disease 
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Inflammatory bowel disease (IBD) may be a major medical drawback. IBD may be a 
general term used for intestinal inflammation, and also the specific diseases and disorders that 
fall into the IBD class embrace Crohn’s disease, ulcerative colitis, and irritable bowel 
syndrome. One amongst the necessary potential medical applications for probiotics is that the 
treatment and prevention of IBD relapses. There are a restricted range of reports of the useful 
effects of probiotics in treating or assuaging IBD symptoms. It's been shown that E. coli 
Nissle is useful in maintaining the remission part for patients with Crohn’s disease. 
Administration of Lactobacillus salivarius in milk to interleukin (IL)-10 knockout mice 
considerably reduced inflammation within the cecum and colon compared with identical 
knockouts fed milk alone. IL-10 is an anti-inflammatory cytokine that causes progressive 
colonic inflammation when levels are low or absent, as is that the case for these knockout 
mice. These results counsel that probiotics, alone or by interaction with the present intestinal 
flora, will influence the colonic immune system and counteract low IL-10 levels. IL-10 is 
often expressed in T cells within the lamina propria of the colon. In another murine model 
study, IL-10 knockout mice treated with a mixture of L. salivarius and Bifidobacterium 
longum subsp. infantis in an exceedingly dairy product resulted in an exceedingly decrease in 
disease severity. The severity of disease was evaluated by weight loss, colon pathology and 
general look over a 6-week amount (McCarthy et al., 2003). Management animals fed solely 
dairy product exhibited a chronic wasting disease throughout identical time amount. A study 
involving thirty two patients with Crohn’s disease in clinical remission and given mesalamine 
or mesalamine and S. boulardii showed that thirty seventh of patients given the drug alone 
relapsed in half-dozen months whereas half-dozen.5% of patients receiving drug and S. 
boulardii relapsed. The knowledge counsel that S. boulardii may well be a helpful adjuvant 
for preventing symptomatic relapse in patients with Crohn’s disease. The total of the present 
human and animal probiotic IBD literature is preliminary and equivocal; but, it will counsel 
that specific probiotics may well be helpful in preventing symptomatic relapse for patients 
with ulcerative colitis and/or Crohn’s disease. 
2.1.4.3 Treatment of gastroenteritis 
The most in depth probiotic medical literature is within the space of diarrheal diseases 
(gastroenteritis).The treatment and prevention may be more categorized by etiologic agent or 
by the sort of disease. 
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2.1.4.3a. Antibiotic-associated diarrhoea 
There are various studies investigating the efficacy of probiotics for preventing or 
reducing the frequency and severity of diarrhoea related to the clinical use of antibiotics 
(Arvola et al., 1995; Vanderhoof et al., 1999; Armuzzi et al., 2001a, b). When finding out 
119 youngsters who received antibiotics for respiratory infections and concomitant 
Lactobacillus rhamnosus GG (LGG) or placebo throughout the antibiotic treatment amount, 
investigators found a seventieth reduction in diarrheal symptoms for the cluster administered 
LGG compared with a placebo arm (Arvola et al., 1995). In an exceedingly larger study 
involving 202 youngsters treated with oral antibiotics, V-E Day of the youngsters who got 
LGG concurrently with antibiotic experienced diarrheal symptoms compared with twenty 
sixth of the placebo cluster (Vanderhoof et al., 1999). In 2 studies with sixty and one hundred 
twenty adult patients respectively receiving antibiotic treatment to eliminate a Helicobacter 
pylori infection, investigators found that a considerably lower variety of patients who 
received concurrent LGG experienced nausea and diarrhoea compared with a gaggle given 
placebo (Armuzzi et al., 2001a,b). Helicobacter pylori are identified as an etiologic agent for 
gastric ulcers. Saccharomyces boulardii has conjointly been shown to cut back antibiotic 
associated diarrhoea (Marchand and Vandenplas, 2000). A meta-analysis of the impact of 
probiotic administration on antibiotic-associated diarrhoea comprising twenty two placebo-
controlled studies found a combined relative risk of 0.39 for diarrhoea among the probiotic-
treated cohorts. The investigators concluded that a robust profit exists for probiotic 
administration for antibiotic-associated diarrhoea, though they cautioned that the proof isn't 
however definitive and a lot of studies are needed. 
2.1.4.3b. Acute diarrhoea 
Numerous studies have reported the employment of probiotics to forestall or treat 
acute diarrhoea (Cetina-Savri and Sierra, 1994; Pant et al., 1996; Shornikova et al., 1997a, b; 
Mastretta et al., 2002; Allen et al., 2003). The bulk of the studies concerned infants or kids 
and therefore the etiologic agent was rotavirus or of unknown cause. Probiotics that are 
shown to be effective for the treatment of acute gastroenteritis embrace LGG, Lactobacillus 
reuteri and S. boulardii (Pant et al., 1996; Shornikova et al., 1997a, b; Mastretta et al., 2002; 
Allen et al., 2003). A multicenter European based mostly trial with 287 kids aged 1–36 
months from ten countries is one amongst the foremost intensive trials investigating probiotic 
treatment for acute diarrhoea reported. The youngsters were experiencing moderate to severe 
diarrhoea. The patients were randomized to be given placebo or LGG together with oral 
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rehydration answer. The youngsters receiving LGG had a shorter period and decreased 
severity of disease together with a shorter hospital keep. Another necessary finding was that 
on follow-up the probiotic treated kids had a decreased probability of persistent diarrheal 
illness. There are alternative samples of findings the same as those described on top of in kids 
with diarrheal disease (Pant et al., 1996; Shornikova et al., 1997b). A review of the double-
blind randomized literature for probiotic biotherapeutic agents found that LGG and S. 
boulardii had the foremost favorable impact for treatment of acute diarrhoea in kids and 
adults (Marchand and Vandenplas, 2000). 
2.1.4.3c. Traveler’s diarrhoea 
Visitors from temperate climate countries when move to areas with tropical or 
subtropical climates, they experience a high incidence of diarrhoea. The incidence rate 
typically approaches five hundredth. There are many printed studies that have investigated 
the efficacy of probiotic treatment for lowering the diarrheal incidence rate. A study that 
tracked Finnish travellers to Turkey showed that in one among 2 resorts oral ingestion of 
LGG conferred a big protection rate of thirty.5% and 27.9% in weeks one and a couple of the 
study respectively. The travelers were given LGG or a placebo before their trip and LGG 
afforded a protection rate of forty seventh (Hilton et al., 1997). (McFarland, 2007) performed 
a meta-analysis of studies designed to analyze probiotics for the prevention of traveler’s 
diarrhoea. The analysis included twelve studies that met the inclusion and exclusion criteria. 
The results of the analysis showed that the pooled relative risk was zero.85 (P < 0.001) which 
probiotics considerably stop traveler’s diarrhoea. The meta-analysis investigator conjointly 
concluded that S. boulardii and a combination of L. acidophilus and Bifidbacterium bifidum 
had important treatment efficacy. 
2.1.4.3d. Treatment of relapsing gastroenteritis caused by Clostridium difficile toxin 
Often as a result of antibiotic treatment, the conventional intestinal microflora is 
altered. The disturbance to the microflora may end up in C. difficile growth from living 
spores, with the concomitant production of toxin within the intestinal tract. Many studies 
have shown that treatment with LGG prevents relapse of gastroenteritis (i.e. recurrent C. 
difficile associated disease, RCDAD) formerly use of antibiotics. Clinical observations have 
indicated an hour relapse rate once therapy with metronidazole or vancomycin. Solely 16 PF 
which have received LGG had a relapse and once a second course of treatment with LGG, 
there was a ninety four overall cure rate. There are many recent studies that have solid doubt 
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on these earlier findings. No profit was found for a yogurt/LGG formulation for patients with 
RCDAD (Pochapin, 2000). In an exceedingly tiny study using capsules containing 
lyophilized LGG there once more was no profit noted with the probiotic, though the study 
had too few subjects to produce statistical power. It's so not clear if probiotics are useful for 
patients with RCDAD. 
2.1.4.4. Cholesterol lowering 
There is some proof based mostly on human studies that probiotics could lower total 
serum cholesterol and/or low-density lipoprotein (LDL) cholesterol. The results don't seem to 
be definitive and sometimes conflicting. The lowering of LDL cholesterol would have vital 
implications for decreasing the danger of coronary artery disease and for fatal myocardial 
infarction. The human studies that have shown a bearing for fermented milk merchandise on 
plasma cholesterol levels found a lowering of total cholesterol between five.4 and 23.2% and 
for LDL between nine and nine.8%. A recent study of fourteen subjects in an exceedingly 
randomized crossover trial involving normal yogurt or yogurt and L. acidophilus and B. 
animalis subsp. lactis for 6-week feeding amounts and a 4-week washout period found a big 
decline in serum total cholesterol when comparing the yogurt and probiotics to the yogurt 
alone. The cholesterol studies have had little numbers of subjects and were restricted in 
length, typically in weeks. Based mostly on in vitro and animal studies, many mechanisms 
for the probiotic lowering of serum cholesterol are proposed. These involve absorption or 
assimilation of cholesterol by probiotics. There has been a study showing optimal removal of 
cholesterol from growth media within the presence of L. casei and a prebiotic (Liong & Shah, 
2005). A separate mechanism that has been proposed for probiotic-induced cholesterol 
lowering is that the ability of bifidobacteria and lactobacilli to deconjugate bile acids. The 
deconjugation would cause additional fast excretion of bile acids within the faeces and since 
cholesterol may be a precursor for bile acid synthesis, the lower bile acid concentration 
would act as a positive feedback for increasing synthesis from cholesterol to bile acids. 
2.1.4.5. Treatment for urogenital infections 
 Vaginal infections are caused by such agents as Candida, Trichomonas, or bacterial 
organisms like Gardnerella vaginalis and Mycoplasma hominis. Urinary tract infections are 
much common in girls and are typically caused by E. coli, Chlamydia and Candida. There are 
approximately three hundred million urogenital infections reported per year. Traditional 
healthy girls have approximately fifty completely different species of microorganisms within 
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the vaginal flora. (Reid et al,. 1995) accounted that weekly intravaginal instillation of 
lactobacilli in ten premenopausal girls reduced urinary tract infections from 6.3 per patient 
per year before treatment to 1.3 per patient per year throughout treatment. (Hilton et al,. 
1992) found that yogurt containing L. acidophilus lowers the Candida-caused vaginitis by 
threefold in an exceedingly crossover-designed trial. The results of studies using probiotics 
for treatment or prevention of urogenital infections are terribly restricted, though there are 
investigators trying to style specific probiotics to be administered orally to stop or cut back 
the incidence of urogenital infections. 
2.1.4.6. Treatment of allergic reactions 
The most in depth studies directed at probiotic modulation of the immune response to 
food allergens are done with LGG for preventing and treating atopic eczema. In an 
exceedingly study of 159 pregnant girls with a family history of atopic disease the themes got 
either LGG or placebo for 2–4 weeks before their expected delivery. Girls who breast-fed 
their infants received LGG or placebo for six months and ladies who bottle-fed their new-
borns fed them LGG or placebo for six months. A five hundredth reduction within the 
incidence of atopic eczema was noted within the 1st a pair of years of the child’s life for the 
cluster receiving LGG compared with the placebo cluster. In an exceedingly follow-up to the 
current study, when four years the youngsters given LGG had a considerably lower incidence 
of atopic eczema compared with the placebo cluster (Kalliomaki et al., 2003). In another 
study twenty seven infants with atopic eczema were randomized into 3 teams and given 
LGG, Bifidobacterium animalis subsp. lactis (Isolauri et al., 2000). When a pair of months 
the clinical score for the severity and extent of the eczema indicated a big improvement 
within the skin condition of the infants fed the probiotics (P = zero.002). an identical study 
within which thirty one infants with atopic eczema had their exposure to cows’ milk 
terminated and were treated with LGG showed a big improvement compared with a gaggle 
who weren't fed cows’ milk and were fed placebo. Bifidobacterium animalis has additionally 
been shown to scale back the severity of atopic eczema in young kids. 
2.1.4.7 Prevention of dental caries 
After oral ingestion, probiotics will be isolated from the oral cavity. Thus it'd be logical to 
review their efficacy in preventing dental caries. Additionally, LGG has been shown to 
possess antimicrobial activity against the Streptococcus spp., an organism concerned in 
inflicting tooth decay (Silva et al., 1987). Kids during a multicenter daycare trial got LGG-
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containing milk or non-supplemented milk and examined before and when the 7-month 
intervention study. The kids receiving the probiotic had a lower rate of clinical development 
of dental caries, that was most pronounced within the cluster aged 3–4 years (Nase et al., 
2001). Lot of studies are required to check if this observation will be repeated and if 
alternative probiotics can have identical useful result. 
2.1.4.8 Treatment and prevention of cancer by probiotics 
By virtue of their metabolic activity, probiotics will influence the etiology of colon cancer 
and presumably tumors at different sites. Probiotics are shown to cut back intestinal bacterial 
enzymes concerned within the activation of procarcinogens (Hosoda et al., 1996). Probiotics 
can also manufacture short-chain fatty acids which will even be protecting within the colon. 
Animal studies in rats have shown that probiotics will inhibit the formation of aberrant crypt 
foci within the colon. Acombination of inulin and B. longum reduced chemically induced 
aberrant crypt foci by seventy four (Rowland et al., 1998). Inulin alone lowers the aberrant 
crypts by twenty first. Rats fed a combination of oligofructose, inulin, LGG and B. animalis 
subsp. lactis had considerably lower azoxymethane-induced colon tumors (Marotta et al., 
2003). Mice genetically bred to be at risk of colitis and colon cancer had a tenth incidence 
rate of adenocarcinoma when fed L. salivarius compared with the five hundred rate for 
management animals (O’Mahoney et al., 2001). Rats injected with DMH and fed LGG had a 
considerably lower colon cancer incidence than animals receiving DMH alone. Human colon 
cancer trials haven't been conducted with probiotics, primarily owing to the problem of 
conducting a preventive intervention trial. There's one report within the literature of an 
individual's trial of patients with superficial bladder cancer. The patients receiving L. casei 
had an eightieth longer disease free amount, with a mean of 350 days compared with 195 
days for the management cluster. 
2.1.4.9. Additional health benefits attributed to probiotics 
There are variety of alternative health edges that are observed for probiotic use over 
the past number of years. Some are included during this section. A study conducted in Italy 
with kids laid low with cystic fibrosis and given LGG for the chronic abdominal pain 
typically related to the disease indicated that the frequency and severity of abdominal issues 
were reduced which intestinal inflammation as judged by the faecal marker calprotectin and 
rectal nitric oxide was conjointly decreased. Rheumatoid arthritis may be a systemic 
inflammatory disease. Animal studies using experimental arthritis model in Lewis rats 
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showed that these rats improved when fed LGG compared with placebo. The findings of a 
preliminary study involving twenty one patients with rheumatoid arthritis receiving either 
placebo or LGG showed that the LGG cluster had a decreased variety of swollen joints and 
lower overall arthritic activity, though the distinction failed to reach statistical significance. 
(Nanji et al., 2005) studied the flexibility of probiotics to stop alcohol-induced liver disease 
during a rat model. Rats were conditioned to drink ethanol and one cluster was administered 
LGG orally. The rats fed LGG had reduced liver disease and lower plasma endotoxin levels. 
During a connected study rats got carbon tetrachloride to induce chronic liver disease as a 
model to check the efficacy of probiotics in spontaneous bacterial peritonitis. LGG wasn't 
effective and failed to stop bacterial overgrowth or bacterial translocation from the colon into 
mesenteric lymph nodes or portal blood. The result of probiotics on radiation exposure has 
been studied during a mouse model (Dong et al., 1987). Mice were either fed LGG or 
maintained on a standard diet and then exposed to total body irradiation. The LGG-fed rats 
had a considerably lower mortality rate at forty eight hours when irradiation. Of the twenty 
one management mice ten had Pseudomonas aeruginosa bacteremia, compared with one of 
twenty one mice fed LGG. None of the LGG-fed mice had LGG bacteremia. There's a 
preliminary study from Japan employing a streptozotocin-induced diabetic mouse model that 
showed that feeding LGG lowered hemoglobin A1c blood levels and improved glucose 
tolerance compared with controls. Bone marrow transplantation patients will develop graft-
versus-host disease (GVHD). Bacterial lipopolysaccharide (LPS) is believed to be concerned 
during this method. A mouse model of GVHD has been developed where the disease is 
induced by using a significant histocompatibility mismatch (Gerbitz et al., 2004). The 
animals show serious injury to the bowel mucosa and high levels of serum LPS and 
inflammatory cytokines. The animals were divided into 3 teams, receiving in their drinking 
water LGG, ciprofloxacin or no additive for seven days before transplantation. Treatment 
with LGG reduced mortality that was most distinguished within the early post-transplantation 
amount and was mirrored during a lower GVHD score compared with the opposite teams. 
Mesenteric lymph nodes of LGG treated animals had a lower concentration of translocated 
intestinal organisms. 
2.1.4.10. Conclusions based on past and present use of probiotics for health applications 
This section has outlined the current knowledge regarding the application of 
probiotics for preventing and treating medical diseases and disorders. Table 1 (Barry., 2011) 
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lists the medical applications for probiotics that have been studied in the past and which are 
currently under investigation. 
 
TABLE 1: Past and Current Applications for Probiotics 
 
 
2.2 LACTIC ACID BACTERIA 
2.2.1. Historical background of lactic acid bacteria 
Lactic acid-manufacturing fermentation is a recent invention. Varied cultures in 
various elements of the planet have used fermentation to enhance the storage qualities and 
nutritive worth of perishable foods like milk, vegetables, meat fish and cereals. The 
organisms that manufacture this kind of fermentation, lactic acid bacteria, have had a very 
important role in preserving foods. In developed world, lactic acid bacteria are mainly related 
to fermented dairy product like cheese, buttermilk, and yogurt. The utilization of dairy starter 
cultures has become an trade throughout this century. 
The concept of the cluster name ‘lactic acid bacteria’ was created for bacteria 
inflicting fermentation and coagulation of milk, and defines as those that manufacture lactic 
acid from lactose. The family name Lactobacteriaceae was applied by (Orla-Jensen, 1919) to 
a physiological cluster of bacteria manufacturing lactic acid alone or acetic and lactic acids, 
alcohol and carbon dioxide. Today, lactic acid bacteria are considered synonymous by and 
huge with the family Lactobacteriaceae (Breed et al., 1957). 
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Since the times of Russian scientist Metchnikoff, lactic acid bacteria have conjointly 
been related to helpful health effects. Today, an increasing range of health food and so-called 
purposeful foods similarly as pharmaceutical preparation are promoted with health claims 
based mostly on the characteristics of sure strains of lactic acid bacteria. Most of those 
strains, however, haven't been completely studied, and consequently the claims aren't well 
substantiated. Moreover, health edges are judged mainly using subjective criteria. 
Additionally, the particular bacterial strains employed in the studies are typically poorly 
identified. Most data regarding the health effects of lactic acid bacteria is therefore anecdotal. 
There's clear want for important study of the result on health of strain choice and therefore 
the quality of fermented foods and their ingredients. 
Lactic acid bacteria are a gaggle of Gram-positive bacteria united by a constellation of 
morphological, metabolic, and physiological characteristics. They're non-sporing, 
carbohydrate-fermenting lactic acid producers, acid tolerant of non-aerobic habitat and 
catalase negative. Usually they're non-motile and don't scale back nitrite. They're subdivided 
into four genera Streptococcus, Leuconstoc, Pediococcus, and Lactobacillus. Recent 
taxonomic revisions counsel that lactic acid bacteria cluster can be comprised of genera 
Aerococcus, Carnobacterium, Enterococcus, Lactobacillus, Lactococcus, Leuconostoc, 
Pediococcus, Streptococcus, Tetragenococcus, and Vagococcus. Originally, Bifidobacteria 
were included within the genus Lactobacillus and therefore the organism was spoken as 
Lactobacillus bifidus. Though the classification of lactic acid bacteria into completely 
different genera is principally based mostly on the characteristics utilized by (Orla-Jensen, 
1919); but, confusion was still prevalent when the monograph of (Orla-Jensen, 1919) 
appeared. This work has had an oversized impact on the systematic of lactic acid bacteria, 
and, though revised to some extent, it's still valid and therefore the basis of classification 
remarkably unchanged. The classification of lactic acid bacteria into completely different 
genera is basically based mostly on morphology, mode of glucose fermentation, growth at 
completely different temperatures, and configuration of the lactic acid created, ability to grow 
at high salt concentrations, and acid or alkaline tolerance. Even a number of the newly 
described genera of lactic acid bacteria, extra characteristics like fatty acid composition and 
motility are used because the basis of classification. The term lactic acid bacteria were used 
synonymously with “milk souring organisms.” Important progress in the classification of 
these bacteria was made when the similarity between milk-souring bacteria and other lactic-
acid producing bacteria of other habitats was recognized (Axelsson, 1993). Lactic acid 
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bacteria are generally associated with habitats rich in nutrients, such as various food products 
(milk, meat, vegetables), but some are also members of the normal flora of the mouth, 
intestine, and vagina of mammals. The genera that, in most respects, fit the general 
description of the typical lactic acid bacteria are (as they appear in the latest Bergey’s Manual 
from 1986) Aerococcus, Lactobacillus, Leuconostoc, Pediococcus, and Streptococcus. The 
genera Lactobacillus, Leuconostoc, and Pediococcus have largely remained unchanged, but 
some rod-shaped lactic acid bacteria, previously included in Lactobacillus, is now forming 
the genus Carnobacterium (Collins et al., 1987). 
2.2.2. Classification at genus level 
The basis for the classification of lactic acid bacteria in different genera has 
essentially remained unchanged since the work of (Orla-Jensen, 1919). Although their 
morphology is regarded as questionable as a key character in bacterial taxonomy (Woese, 
1987), it is still very important in the current descriptions of the lactic acid bacteria genera. 
Thus lactic acid bacteria can be divided into rods (Lactobacillus and Carnobacterium) and 
cocci (all other genera). An important characteristic used in the differentiation of the lactic 
acid bacteria genera is the mode of glucose fermentation under standard conditions, i.e., non-
limiting concentrations of glucose and growth factors (amino acids, vitamins and nucleic acid 
precursors) and limited oxygen availability. Under these conditions, lactic acid bacteria can 
be divided into two groups: homofermentative, which convert glucose almost quantitatively 
to lactic acid, and heterofermentative, which ferment glucose to lactic acid, ethanol/acetic 
acid, and CO2. In practice, a test for gas production from glucose will distinguish between the 
groups. Leuconostocs and a subgroup of Lactobacillus are heterofermentative; all other lactic 
acid bacteria are homofermentative. 
Growth at certain temperatures is mainly used to distinguish between some of the 
cocci. Enterococci grow at both 10
0
C and 45
0
C, Lactococci and Vagococci at 10
0
C, but not at 
45
0
C. Streptococci do not grow at 10
0
C, while growth at 45
0
C in dependent on the species 
(Axelsson, 1993). Salt tolerance (6.5% NaCl) may also be used to distinguish among 
Enterococci, Lactococci/Vagococci, and streptococci, although variable reactions can be 
found among Streptococci. Extreme salt tolerance (18% NaCl) is confined to genus 
Tetragenococcus. Tolerances to acid and/or alkaline conditions are also useful characteristics. 
Enterococci are characterised by growth at both high and low pH. The formation of the 
different isomeric forms of lactic acid during fermentation of glucose can be used to 
25 | P a g e  
 
distinguish between Leuconostoc and most heterofermentative lactobacilli, as the former 
produce only D-lactic acid and the latter a racemate (DL-lactic acid). 
 
2.2.3 Metabolism of lactic acid bacteria 
The essential feature of lactic acid bacteria metabolism is efficient carbohydrate 
fermentation coupled to substrate-level phosphorylation. The generated ATP is subsequently 
used for biosynthesis purposes. Lactic acid bacteria as a group exhibit an enormous capacity 
to degrade different carbohydrates and related compounds. Generally, the predominant end 
product is of course, lactic acid (> 50% of sugar carbon). It is clear however, that lactic acid 
bacteria adapt to various conditions and change their metabolism accordingly. This may lead 
to significantly different end-product patterns.  
2.2.4 Grouping of Lactobacillus 
The primary interest of (Orla-Jensen’s, 1919) early description of the lactic acid 
bacteria was directed to identify these bacteria useful in the dairy industry, with the particular 
interest in the study of those bacteria occurring in Danish ‘dairy cheese’. Orla-Jensen 
recognized 10 species in his time. This number increased only slowly to 15 and 25 species, in 
the 7
th
 and 8
th
 editions of Bergey’s Manual respectively. Finally 44 species have been 
recognized in the latest 9
th edition of Bergey’s Manual. The numbers of species are still 
increasing due to emerging of new taxonomic methods, which allow a more precise 
identification of strains isolated some time ago and, to some extent, from the continued 
investigation of habitats. The latest grouping of lactobacilli by (Kandler and Weiss, 1986) 
relies on biochemical-physiological criteria and neglects classical criteria of Orla-Jensen such 
as morphology and growth temperature since many of recently described species did not fit 
into the traditional classification scheme. Unfortunately, the description of new species 
usually does not include the analysis of the end products derived from the fermentation of 
pentoses, and therefore, the enzymes of the pentose phosphate pathway may be present 
permitting a homofermentative metabolism of pentose in lactobacilli. Nevertheless, 
maintaining the traditional terms is justified with regards to hexose utilization. However, at 
low substrate concentration and under strictly anaerobic conditions, some facultatively 
heterofermentative species may produce acetate, ethanol and formate instead of lactate from 
pyruvate. Thus, the definitions have to be used in awareness of their limitations. 
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When glucose is used as a carbon source, lactobacilli could be homofermentative or 
heterofermentative. When homofermentative, they could produce more than 85% lactic acid, 
whereas the heterofermentative strains produce lactic acid, carbon dioxide, ethanol or acetic 
acid. In the presence of oxygen or other oxidants, increased amounts of acetate may be 
produced at the expense of lactate or ethanol. A total of 56 species of lactobacilli have been 
divided into three metabolic groups (Hammes and Vogel, 1995). 
 
 Group A: Obligatory homofermentative lactobacilli: Hexoses are fermented to lactic 
acid by EMP pathway. Pentose or gluconate are not fermented. 
 Group B: Facultatively heterofermentavie lactobacilli: Hexoses are fermented to 
lactic acid by EMP pathway. The organisms possess aldolase and phosphoketolase 
and therefore, not only ferment hexose but alsopentoses (and often gluconate). In the 
presence of glucose, the enzymes of the phosphogluconate pathway and may be 
fermented. 
 Group C: Obligatory heterofermentavie lactobacilli: the phospogluconate pathway 
ferments hexoses, yielding lactate, acetic acid (ethanol) and CO2 in equimolar 
amounts. Pentose enters in this pathway and may be fermented. 
 
Within these three groups the species are arranged according to their phylogenetic 
relationship. The letter indicates the affiliation of the L. delbrueckii group, b to the L. casei-
Pediococcus group. Thus, the combination of the letter Aa defines a species as belonging to 
the obligatory homofermentative lactobacilli affiliated in the L. delbrueckii group, whereas 
Cb means that the species is obligatory heterofermentative phylogenetically belonging to the 
L. casei-Pediococcus group, etc. The L. casei species belonging to the group facultatively a 
heterofermentavie organism comes under group B. Two species, L. acetotolerans and L. 
hamsteri constitute group Ba, meaning that phylogenetically these organisms fall into the L. 
delbrueckii group. The presence of the Lys-Dasp type peptidoglycan is consistent with this 
grouping. 
Group Bb contains 15 species, 12 of which contain Lys-Dasp and three DAP in their 
peptidoglycan. In contrast to (Kandler and Weiss, 1986), (Hammes and Vogel, 1995) have 
included into group Bb L. bifermentans since, in agreement with the group definition; this 
organism possesses key enzymes, aldolase and phosphoketolase. L. bifermentans is 
characterized by fermenting glucose homofermentatively. However, dependent on the pH, 
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lactate can be metabolized to ethanol, acetic acid and CO2 and H2. The utilization of lactate 
(and/or pyruvate) is rather common for group Bb-organisms. It can be foreseen that changes 
will occur for the species L. casei and L. paracasei. With ample evidence, (Dellaglio et 
al,.1991) presented a request for an opinion. They showed that the type strain of L. casei 
(ATCC 393) is not genetically closely related to several subspecies of L. casei as they were 
described by (Kandler and Weiss, 1986). This had led (Collins et al,. 1989) to describe L. 
paracasei sp. Nov. that included these types of strains. It appears, however, that the species 
L. paracasei should be rejected and changed for L. casei. The type strain of L. casei would 
have to be allotted to a new species that includes also one strain of L. rhamnosus and L. zeae. 
2.2.5 Taxonomic diversity of Lactobacillus 
The human gastrointestinal tract contains hundreds of different bacterial species. 
(Tannock, 1995). Members of the genus Lactobacillus are commonly present as members of 
microbial communities and have received considerable attention with respect to their putative 
health conferring properties as probiotics. Lactobacillus has worldwide industrial use as 
starters in the manufacturing of fermented milk products. Moreover, some of Lactobacillus 
strains have probiotic characteristics and are therefore included in fresh fermented products 
or used in capsular health products, such as freeze-dried powder. The use of some 
Lactobacillus strains as probiotics is based on studies that show that these species belong to 
the normal intestinal flora and that the strains have beneficial effects on human and animal 
health (Salminen et al., 1996). Major bacterial species isolated from human gastrointestinal 
tract fall generally into three distinct categories. These include: 1) Organisms almost always 
present in large number, and constituting the indigenous and resident flora, e.g. Bacteroides, 
Bifidobacterium; 2) Organisms normally present in small or moderate numbers, and part of 
the resident flora, e.g. Enterobacteriaceae, Streptococcus and Lactobacillus; and 3) 
Organisms present in small numbers, probably contaminants from other regions of the body 
e.g. Staphylococcus, Haemophilus, etc., or from the environment, e.g. Bacillus, 
Corynebacterium, which constitute transient flora. More specifically, organisms of the human 
gastrointestinal tract include diverse bacterial genera or families, and are divided into the 
following three groups: 1) Lactic acid bacteria in a broad sense, including Bifidobacterium, 
Lactobacillus, and Streptococcus (including Enterococcus); 2) Anaerobic group, including 
Bacteriodaceae, Eubacterium, Peptococcaceae, Veillonella, Megasphera, Hemmiger, 
Clostridium and Treponema; and 3) Aerobic group, including Enterobacteriaceae, 
Staphylococcus, Bacillus, Corynebacterium, Pseudomonas and yeasts.  
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3. OBJECTIVES 
 
 
1) Isolation of LAB from fish intestine by growing on Lactobacillus selective media 
(MRS) in anaerobic Condition. 
2) Selection of LAB by amplification of Lactobacillus specific gene. 
3) Inhibitory action of isolated LAB strains against Bacillus sp., Klebsiella sp., Proteous 
sp., E. coli, and Pseudomonas sp. 
4) Identification of potential probiotic LAB by biochemical as well as molecular 
characteristics. 
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4. MATERIALS AND METHODOLOGY 
 
4.1 SAMPLE COLLECTION: 
Fresh water fish intestine 
Fresh water fishes such as Kau (Anabas scandens), Singhi (Heteroneuster fossilis) were 
obtained from Pahad kata fish market, Rourkela, Odisha in living condition. 
4.2 ISOLATION OF LACTIC ACID BACTERIA: 
 From fish intestine 
The ventral surfaces of the fishes were sterilised using 70% ethanol and aseptically dissected 
to remove intestines. The intestines were opened by a longitudinal incision and thoroughly 
flushed with sterilised chilled normal saline solution (NSS) to remove feed materials, dirt and 
other impurities. Then the intestines were homogenised with normal saline solution (0.87% 
NaCl) in sterile mortar and pestle. The homogenised intestines were centrifuged at 5000 rpm 
for 5minute.The supernatants were serially diluted up to 10
-6
 dilutions. From 10
-3
, 10
-4
, 10
-5
 
and 10
-6
 dilutions, 100 µl of samples were plated by spread plate method on prepared MRS 
agar plate adjusted with different pH i.e. 3.5, 4.5, 6.5, 7.5 and incubated anaerobically at 37
0
C 
for 48 hrs. 
4.3. IDENTIFICATION OF LACTIC ACID BACTERIA 
Identification of the isolates were performed according to their morphological, cultural 
and biochemical characteristics by following Bergey’s Mannual of Systematic 
Bacteriology (Kandler and Weiss, 1986) 
4.3.1 MORPHOLGICAL IDENTIFICATION 
(i) Gram Staining Method 
Gram staining (or Gram's method) is an empirical method of differentiating bacterial 
species into two large groups (Gram-positive and Gram-negative) based on the chemical, 
primarily the presence of high levels of peptidoglycan, and physical properties of their 
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cell walls . The Gram stain is almost always the first step in the identification of a 
bacterial organism. While Gram staining is a valuable diagnostic tool in both clinical and 
research settings, not all bacteria can be definitively classified by this technique, thus 
forming Gram-variable and Gram-indeterminate groups as well. A Gram positive results 
in a purple/blue colour while a Gram negative results in a pink/red colour. 
 In Gram staining the single colony from the agar plate was taken & placed on the 
grease free slide.  
 The smear was air-dried and then heat fixed.  
 Then the slide was treated with crystal violet for 1 min followed by washing with 
running distilled water. 
 Then Gram’s iodine for 1 min followed by washing with running distilled water. 
 After that the slide was treated with alcohol for 30 sec. 
 Finally the slide was counterstained with safranin for 30 sec followed by washing 
with running distilled water. 
 Then it was air dried & then examined under microscope to know the morphology of 
bacteria. 
 
(ii) Colony Morphology 
Cultures in the petriplate were examined to study colony morphology. 
 
4.4 BIOCHEMICAL ANALYSIS 
Biochemical identification of the isolated strains was done by using Biochemical 
identification kit (HI Bacillus identification kit, HIMEDIA) and some manual 
biochemical methods. Biochemical Identification test kit is a standardized colorimetric 
identification system utilizing conventional biochemical tests and carbohydrate 
utilization tests. The tests are based on the principle of pH change and substrate 
utilization. On incubation organisms undergo metabolic changes which are indicated by a 
colour change in the media that is either interpreted visually or after addition of a 
reagent. The biochemical test includes different sets of tests like as follows: 
4.4.1 Catalase Test 
The catalase test was performed to detect the presence of catalase enzyme, by 
inoculating a loopful of culture into tubes containing 3% hydrogen peroxide solution. 
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Positive reaction was indicated by formation of effervescence or appearance of bubbles, 
due to the breaking down of hydrogen peroxide to O2 and H2O. 
4.4. Oxidase Test 
         This oxidase test was done with the help of a commercially available disc coated with a 
dye N-tetramethylparaphenylenediaminedihydrochloride (HI media), to detect the 
presence of cytochrome ‘C’ oxidase which is responsible for the oxidation of the dye. 
Rubbing a little quantity of the bacterial culture by means of a sterile toothpick on the 
disc causes formation of purple colour within 10-30 sec indicating positive reaction 
whereas no colour change indicates negative reaction. 
         4.4.4 Motility Test 
The motility test was done to determine the motility of the organism. Bacterial cultures 
were stabbed into the motility test medium (HI media) and were incubated at 37ºC for 
48h.Turbidity and observation of growth besides the stab line indicated a positive 
reaction whereas clear visibility with growth along the stab line indicated a negative 
reaction. 
         4.4.3 Endospore Formation Test 
The endospore formation test was performed for all isolated strains to observe the spore 
formations. The purpose of this test is to differentiate between the microorganism 
which produce endospore and which are not. Spores have a durable outer coating that is 
composed of the protein keratin.  This keratin coat resists staining so in order to stain a 
spore the primary stain, malchite green, must be heated to drive the stain into the 
spores. Vegetative cells are then decolorized with water and 0.5% safranin is used to 
counterstain. Thus endospores are stained green, while vegetative cells are stained red. 
1. The smear of 4-5 days old bacterial culture was made on the cleaned glass slide. 
2.  The smears were heat fixed. 
3. The smears were covered with a piece of absorbent paper cut to fit the slide and place 
the slide on wire gauze on a ring stand.  
4. The paper is saturated with malachite green and holding the Bunsen burner in the 
hand the slide was heated until steam can be seen rising from the surface.  Heat was 
removed and reheated the slide as needed to keep the slide steaming for about three 
minutes. 
32 | P a g e  
 
5. The paper was removed with forceps and rinsed the slide thoroughly with tap water. 
6. The slide was drained and counterstained 45 seconds with 0.5% safranin. 
7. Then the slide was washed, dried and examined. 
8. Slides were observed under microscope. The vegetative cells will appear red and the 
spores will appear green. 
4.5 CONFORMATION OF LACTIC ACID BACTERIA 
4.5.1 Amplification of Lactobacillus genus specific gene 
The primers used for the study taken from the published papers in heterologous species. 
The Lactobacillus genus specific primer pairs were used to amplify 327 bp products 
from bacterial cell lysate. First the master mix was prepared, from which 23.75μl was 
mixed to 1.25μl of each bacterial cell lysate sample. Each PCR reaction consisted of 
20.35μl dH2O, 2.5μl 10X buffer (HIMEDIA), 0.25μl dNTPs (Chromus Biotech), 0.5μl 
of each forward and reverse primer, followed by 0.5μl Taq DNA polymerase 
(HIMEDIA). All amplification reactions consisted of an initial denaturation at 96C for 
5 min prior to 30 cycles of 95C denaturation for 15 seconds, at appropriate annealing 
temperature 52C for 30 seconds   and 72C extension for 1 min, followed by a final 
72C extension for 10 min. Then the PCR product was stored at   40C until further use. 
The generated PCR products (8μl) were then analysed by electrophoresis on 1% 
agarose gel. 
Forward primer: 5’ AGCAGTAGGGAATCTTCCA 3’ 
Reverse primer: 5’ ATTYCACCGCTACACATG 3’ 
PCR condition 96ºC/5 min, (94ºC/15 sec, 52ºC/30 sec, 72ºC/1 min)30 cycle, 72ºC/10 min, 4ºC/∞ 
4.6 BACTERIOCIN ASSAY BY WELL DIFUSION METHOD 
 LAB strains were previously cultured in MRS broth was centrifuged at 5000 rpm for 
10 minutes. 
 Cell free supernatant was filtered through 0.22 µm syringe filter and collected in 
sterile vials. 
 Pre-incubated MHA plates were punched with sterile 5 mm cork borer to make 
uniform wells. 4-5 wells were made in each MHA plate. 
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 All Pathogenic strains were mixed with NSS separately and density was adjusted by 
comparing with 0.5 Mc. Farlands standard as described above. 
 Indicator organisms were streaked at 600 rotations in MHA plates with sterilised 
cotton swabs. 
 200µl of LAB supernatant filtrate was poured into the well. 
 All the plates were labelled and incubated aerobically at 370 C for 24-48 hrs. 
 After incubation inhibition zone size was measured in millimetre scale. 
 
4.7 FURTHER IDENTIFICATION OF POTENTIAL LAB 
4.7.1 Biochemical Analysis 
4.7.1.1 Gas Prodution from Glucose 
Gas production from glucose was assessed by inoculating the isolated strains in MRS 
broth containing glucose (1%) containing Durham tube in inverted condition and 
incubated at 37ºC for 48-72 hrs. The upward movement of inverted Durham tube 
indicates positive reaction (gas production). 
 
4.7.1.2 Malonate Utilisation 
Malonate utilisation test was performed to observe the utilisation of malonate present 
in the Malonate test medium (Himedia). Malonate test medium contains 
Bromothymol blue as indicator. Sodium malonate is the carbon source and 
ammonium sulphate is the nitrogen source. Organisms, which are able to utilise 
malonate, release sodium dioxide. The resulting alkaline conditions cause the 
indicator to change from light green to blue. Colour of the medium changes from light 
green to blue if the test is positive. Medium remains light green in colour if the test is 
negative. 
 
4.7.1.3 Voges Proskauer’s Test 
Some organisms have the ability to produce a neutral end product acetoin from 
glucose utilisation. This can be detected by adding 1-2 drops of Baritt reagent A and 
1-2 drops of Baritt reagent B to the biochemical kit (after 48 hrs incubation). A 
positive test showing pinkish red colour within 2-5 min. No amendment in colour 
indicates negative result.  
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4.7.1.4 Citrate Utilisation Test 
The citrate utilisation test was performed to test the ability of bacteria to convert 
citrate (an intermediate of the Kreb’s cycle) into oxaloacetate (another intermediate of 
the Kreb’s cycle). In this media, citrate is that the solely carbon source available to the 
bacteria. The change of medium colour to a bright blue as a result of an increase in the 
pH was considered as positive result.  
 
4.7.1.5 Nitrate Reduction Test  
This test was performed to test whether microorganisms could able to convert nitrate 
to nitrite or not by the addition of 1-2 drops of sulphanilic acid and 1-2 drop of N, N-
Dimethyl-1-Napthylanine reagent to kit medium. Immediate development of pinkish 
red colour on addition of reagent indicated positive reaction. No change in colour 
indicated a negative reaction. 
 
4.7.1.6 Arginine Decarboxylation Test 
The arginine decarboxylation test was performed to detect arginine decarboxylation. 
The medium of this test contains Bromocresol purple as pH indicator. When 
carbohydrate present in the medium is utilised, pH was lowered due to acid 
production changing the colour of the medium to yellow. The acid produced 
stimulated decarboxylase enzyme which caused the formation of amine due to this 
reaction increased in pH of the medium, converting the colour of the indicator from 
olive green to light purple which is a positive result and no change in colour indicated 
negative result. 
 
4.7.1.7 ONPG Test 
Two enzymes, permease and galactosidase are required to lactose fermentation. True 
non-lactose fermenters are barren of both enzymes; however some organisms may 
lack permease but possess the enzyme galactosidase. O-nitro phenyl-D-
galactopyranoside (ONPG) is structurally similar to lactose. Medium changed from 
colourless to yellow if the test was positive and the medium remained colourless if the 
test was negative. 
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4.7.1.8 Esculine Hydrolysis  
Esculine is substituted glucoside that can be hydrolysed by bacteria to yield glucose 
and esculetin. The latter combines with ferric ions in the medium to form black 
coloured complex. Colour of the medium changed from cream to black if the test was 
positive and the medium remained cream in colour if the test was negative. 
 
4.7.2 Molecular identification (16s rDNA Sequencing) 
The 16S rDNA sequence was amplified using 16S universal primers (B27F and 
U1492R) of 1.53 kb size. First the master mix was prepared, from which 23.75μl was 
mixed to 1.25μl of each bacterial cell lysate sample. Every PCR reaction consisted of 
20.35μl dH2O, 2.5μl 10X buffer (HIMEDIA), 0.25μl dNTPs (Chromus Biotech), and 
0.5μl of each forward and reverse primer, followed by 0.5μl Taq DNA polymerase 
(HIMEDIA). All amplification reactions consisted of an initial denaturation at 96C for 
5 min prior to 30 cycles of 95C denaturation for 15 seconds, at appropriate annealing 
temperature 49C for 30 seconds and 72C extension for 1 min, followed by a final 
72C extension for 10 min. Then the PCR product was stored at 4
0
C until further use. 
The generated PCR products (8μl) were then analysed by electrophoresis on 1% 
agarose gel. The PCR product was sent for sequencing. 
Universal 16s Forward Primer (B27F): 5’ AGAGDDDGATCCPGGCTCAG 3’ 
Universal 16s Reverse Primer (U1492R): 5’ GGTTACATTGTTACGACTT 3’ 
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 5. RESULTS  
 
5.1 GROWTH IN MEDIA 
 
 After 2-3 days of incubation growth was observed on MRS agar plate 16 colonies 
have been isolated by observing colony morphology, pure cultured and stored in soft 
agar tube. 
 Out of 16 colonies, 6 colonies were selected on the basis Lactobacillus specific 
biochemical tests and were grown in MRS broth and yellow precipitate was observed 
at the bottom of the tube. 
 All the selected strains shown both aerobic and anaerobic growth. 
 
5.2 MORPHOLOGICAL IDENTIFICATION 
 (A) Gram Staining 
All the 6 isolated strains KT2W, KT1, KT1B, KT1T, KA2, FS were found to be Gram 
positive. 
 
(B) Colony morphology 
 All the 6 selected strains named KT2W, KT1, KT1B, KT1T, KA2, FS  were found to 
be  convex and flat, entire margin, brown, white and transparent, single rods and in 
chain. 
 Based on colony morphology, cell shape, cell arrangement all the 6 strains were 
subjected to further study. 
 
5.3. BIOCHEMICAL IDENTIFICATION 
 
5.3.1 Catalase activity 
All the isolates were subjected to catalase test showed no effervescence on reacting 
with H2O2 and thus were catalase negative. 
 
     5.3.2 Oxidase activity 
All the isolates were oxidase negative as no colour change was observed on the 
oxidase disc rubbed with the broth culture of the isolates. 
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      5.3.3 Endospore formation 
All the isolates were non-endospore forming as no green coloured spore has been 
seen under microscope after staining with malachite green. 
 
  5.3.4 Motility test 
This test was done to determine the motility of the organism and all the isolates were 
found to be non-motile as there was no turbidity and growth resumed only along stab 
line. 
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FIGURE 1: Lactobacillus genus specific gene amplification (1: Marker, 3, 4, 5: KT2W, KT1 
and KT1B respectively)   
 
 
 
FIGURE 2: Lactobacillus genus specific gene amplification (1: Marker, 2, 3, 4: KT1T, KA2 
and FS respectively) 
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TABLE 2. Bacteriocin Assay by Agar well diffusion method 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 3: Bacteriocin Activity Test 
Sl.No. PATHOGEN KT2W KT1 KT1T KTIB KA2 FS 
1 E.Coli +++ +++ +++ ++ ++ ++ 
2 Pseudomonas sp. _ ++ + ++ ++ ++ 
3 Bacillus sp. +++ +++ +++ +++ ++ ++ 
4 Proteus sp. +++ +++ ++ ++ ++ +++ 
5 Kleibsella sp. ++ +++ ++ ++ ++ +++ 
KT1 
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TABLE 3. Biochemical characteristics of the isolated strains  from kitchen waste and fresh 
water fish intestine (KT2W, KT1, KT1T, KT1B, KA2, FS) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sl No. Tests KT1 
1 Gram stain + 
2 Catalase activity _ 
3 Oxidase activity _ 
4 Endospore formation _ 
5 Motility _ 
6 Gas production from 
Glucose 
_ 
7 Malonate + 
8 V.P. _ 
9 Citrate + 
10 Nitrate Reduction + 
11 Arginine _ 
12 O.N.P.G. _ 
13 Esculine Hydrolysis + 
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FIGURE 4: 16S rDNA amplification (A: Molecular weight marker, B: Amplified 16S rDNA 
sequence of KT1 strain) 
 
 
 
1.53 kb 
 
A B 
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6. DISCUSSION 
A cursory review of literature indicates that strains of L. casei and L. delbrueckii have 
beneficial effects against watery diarrhea in infants, decreasing lactose intolerance in adults, 
has anti-cancerous properties, reducing cholesterol and leading to irritable bowel disease 
(IBD)(Anderson et al., 2001). 
Isolation of Lactobacillus strains has been accomplished by using Lactobacillus 
selective medium MRS agar (HIMEDIA). Sixteen strains has been isolated and subjected to 
further study. Six Strains KT1, KT2W, KT1T, KT1B, KA2 and FS were selected as they 
were gram positive, oxidase negative, catalase negative bacilli. Similar result was found by 
(Sharp, 1979; Bukola, 2008; Ali, 2011). Above six strains were also confirmed as belong to 
LAB by amplifying the Lactobacillus genus specific primer designed from regions of identity 
within the 16S ribosomal DNA (rDNA) sequence (Byun et al., 2004). 
All the strains were found to be facultative anaerobes, as the strains grown in 
anaerobic condition under candle jar condition in CO2 incubator and growth also found in 
presence of oxygen. Similar results were found by Gibson et al., 2005, Markiewicz, 2005, 
Sawet et al., 2011.  
The stages of the pre-identification based on morphological aspects showed that LAB 
strains were Gram positive rods found in chain, singly and in pairs. Their colonies were 
circular (KTI, KT2W, KT1B, KT1T, KA2), flat (FS), low convex with entire margin, as 
reported by (Markiewicz, 2005, Edna et al., 2006, Bukola, 2008; Baukhemis, 2009, Pati et 
al., 2010). 
All the 6 isolates were subjected to different biochemical tests results. Isolates were 
subjected to test, gas production from Glucose by adding 1% glucose in MRS broth with 
inverted Durham tube. After 48 hrs of incubation gas was not produced by all the strains. 
Similar result was reported by (Edna et al., 2006; Baukhemis, 2009; Ali, 2011). 
Four to seven days old cultures were subjected to endospore staining test, all the 
strains were found to be non-spore forming (Adesokan, 2009; Hoque et al., 2010). 
Then non-spore forming strains were tested for motility in Manitol Nitrate Motility agar 
(Himedia). All the strains were found to be non-motile as turbidity was absent and growth 
found along stab line only.  
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The isolation of Lactobacillus species from fresh water fish intestine has been carried 
out. Strains KTIT, KT2W, KT1B, KA2 and FS have been identified as Lactobacillus casei 
and the strain KT1 as Lactobacillus delbrueckii according to the characteristics followed in 
Bergey’s manual and in the prokaryotes (Hargrove et al., 1978; Hoizapfel et al., 1992). 
Presently, bacterial species identification using the 16S rDNA-based method is the most 
widely accepted, as large public domain sequence databases were are available in genebank 
for comparasion (Rauta et al., 2011; Maidak et al., 1996; Peer et al., 1997). In the current 
study, the 16S rDNA sequences of above discussed six strains were amplified and sequenced. 
But the sequences are yet to be analyzed for molecular confirmation. 
As shown in Table 2, the antimicrobial spectra of LAB strains were assessed against 
E.coli, Pseudomonas sp., Bacillus sp., Proteus sp. and Kleibsiella sp. All srains showed 
maximum inhibition against E.coli and Proteus sp. All strains except KT2W showed 
inhibition zone against Pseudomonas sp.  L.casei and L.delbrueckii is effective against genera 
Listeria, Enterococcus and Salmonella is reported by (Edna et al., 2006). (Adekosan et al., 
2009) reported the antagonism against Pseudomonas aeriginosa, Staphylococcus aureus. 
Boukhemis in 2009 reported the antagonist activity against E.coli. LAB strains showing 
effective inhibition spectra can be used as probiotics to replace chemical antibiotics in animal 
and in fish –feed industry. Considering probiotic properties, all the isolated strains can be 
used as potential probiotics with further detailed studies.  
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7. CONCLUSION 
The use of probiotics in enhancing the gut microflora of human, animals and in fishes 
shows signs of becoming a success which infers that the isolated strains can be used as 
probiotics both in human and fishes after proper certification. Six strains were screened under 
harsh conditions of acid by lowering the pH of the media. All the isolates showed good to 
excellent acid tolerance, which support the fact that the strains can be survive under acidic 
conditions in the GI. KT1 out of these different strains of L. casei and were assessed against 
five enteric pathogenic genera like Kleibsiella sp., Proteus sp., Pseudomonas sp., E.coli, 
Bacillus sp. Inhibition zone was observed due to production of bacteriocin-like compound. In 
this study Bacteriocin activity test results proved KT1 strain more potential probiotic Lactic 
Acid Bacteria.  Hence this strain can be used against disease caused by the above mentioned 
enteric pathogens.  
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